We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.4B
AUM Growth
-$79M
Cap. Flow
-$151M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.15%
Holding
1,305
New
241
Increased
339
Reduced
426
Closed
291

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$166M
2
BNS icon
Scotiabank
BNS
+$139M
3
TD icon
Toronto Dominion Bank
TD
+$129M
4
CVE icon
Cenovus Energy
CVE
+$117M
5
PBA icon
Pembina Pipeline
PBA
+$89.3M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$85.9M
2
NVDA icon
NVIDIA
NVDA
+$70.9M
3
CIXX
CI Financial Corp.
CIXX
+$70.7M
4
MSFT icon
Microsoft
MSFT
+$68.2M
5
GRP.U
Granite Real Estate Investment Trust
GRP.U
+$63.1M

Sector Composition

Rank Sector Weight
1 Financials 27.05%
2 Technology 13%
3 Energy 12.62%
4 Industrials 11.87%
5 Materials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTG icon
851
Heritage Insurance Holdings
HRTG
$989M
$336K ﹤0.01%
47,013
+16,858
+56% +$104K
CHH icon
852
Choice Hotels
CHH
$4.71B
$335K ﹤0.01%
+2,366
New +$340K
JCI icon
853
Johnson Controls International
JCI
$91.7B
$334K ﹤0.01%
5,090
-4,904
-49% -$338K
BAP icon
854
Credicorp
BAP
$29.8B
$333K ﹤0.01%
+1,938
New +$293K
GLDG
855
GoldMining Inc
GLDG
$226M
$329K ﹤0.01%
+192,400
New +$321K
MDGL icon
856
Madrigal Pharmaceuticals
MDGL
$11.7B
$329K ﹤0.01%
3,349
-1,096
-25% -$92.4K
ATEX icon
857
Anterix
ATEX
$1.79B
$324K ﹤0.01%
5,604
-1,502
-21% -$82.2K
SUZ icon
858
Suzano
SUZ
$9.84B
$322K ﹤0.01%
+27,705
New +$313K
QFIN icon
859
Qfin Holdings
QFIN
$1.52B
$321K ﹤0.01%
+20,847
New +$390K
RCKY icon
860
Rocky Brands
RCKY
$353M
$320K ﹤0.01%
7,705
-16,439
-68% -$703K
TNK icon
861
Teekay Tankers
TNK
$2.9B
$316K ﹤0.01%
+22,823
New +$277K
TW icon
862
Tradeweb Markets
TW
$22.3B
$315K ﹤0.01%
3,587
-12,106
-77% -$1.05M
LUMO
863
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$315K ﹤0.01%
33,367
-60
-0.2% -$536
AVNS
864
DELISTED
Avanos Medical
AVNS
$314K ﹤0.01%
+9,373
New +$302K
YMAB
865
DELISTED
Y-mAbs Therapeutics
YMAB
$314K ﹤0.01%
+26,443
New +$272K
RUBY
866
DELISTED
Rubius Therapeutics, Inc
RUBY
$314K ﹤0.01%
+56,927
New +$362K
RDFN
867
DELISTED
Redfin
RDFN
$311K ﹤0.01%
+17,239
New +$444K
HBCP icon
868
Home Bancorp
HBCP
$569M
$308K ﹤0.01%
7,543
+437
+6% +$17.8K
MUX icon
869
McEwen Inc
MUX
$1.14B
$307K ﹤0.01%
36,582
+34,722
+1,867% +$300K
JOBS
870
DELISTED
51job Inc
JOBS
$306K ﹤0.01%
+5,230
New +$268K
SPWR
871
DELISTED
SunPower Corporation Common Stock
SPWR
$305K ﹤0.01%
+14,180
New +$261K
INSM icon
872
Insmed
INSM
$27.6B
$302K ﹤0.01%
+12,860
New +$299K
PHR icon
873
Phreesia
PHR
$780M
$301K ﹤0.01%
11,408
+3,523
+45% +$108K
ERIE icon
874
Erie Indemnity
ERIE
$13.4B
$298K ﹤0.01%
+1,694
New +$304K
AON icon
875
Aon
AON
$75.7B
$297K ﹤0.01%
+913
New +$266K
33 34
35
36 37

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 Portfolio in Review

As of Q1 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,305 positions worth $20.4B, down 0.39% from $20.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 filing shows 241 new, 339 increased, 426 reduced and 291 closed positions. Its largest new stake was CVS Health: 264,540 shares worth $26.8M. The largest sale was Cameco, an estimated $85.9M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2022 buy was CVS Health: 264,540 shares worth $26.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Enbridge in Q1 2022, an estimated $166M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2022 reduction was Cameco, cutting an estimated $85.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $21.5M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 31% of its $20.4B portfolio in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 241 new positions and closed 291 in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 0.39% quarter-over-quarter to $20.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.